Saturday, July 11, 2026

pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON

Disc Medicine

Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip

321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
443
Patents
706
Clinical program

NL66938.041.19

Phase 1 · other · colorectal liver metastases

NL66938.041.19 for colorectal liver metastases is a Phase 1 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Internal code NL66938.041.19

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Disc Medicine
Phase
Phase 1
Modality
other
Indication
colorectal liver metastases
Status
active
Trials
1

Clinical trials